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Introduction 4 
The Role of Endotoxin Receptors LBP and TLR4 in 
Mycobacterium tuberculosis Infection 
1 Introduction 
1.1 The Immune System 
In the course of evolution, multicellular organisms have developed immune mechanisms that 
render them inhospitable to invading microorganisms. These mechanisms are able to 
differentiate self from non-self, and to further identify the pathogen present in order to mount 
the most effective response. This comprises two distinct components: the innate immune 
system and the acquired immune system. The innate immune system functions immediately 
upon infection and requires no prior exposure to the pathogen. It is based primarily upon 
phagocytic cells, which engulf pathogens and subsequently elaborate cytokines and 
chemokines that orchestrate inflammation and prime the development of the acquired immune 
response. When a foreign invader eludes the mechanisms of the innate immune response, a 
more specific acquired immune response is elicited. Acquired immunity is mediated by B and 
T lymphocytes expressing unique receptors with remarkable antigen-specificity. These cells 
are clonally expanded upon engagement of their receptor by appropriate antigen. The nature 
of pathogen determines the types of stimuli generated by the innate immune response, and 
hence the appropriate polarisation of acquired immunity. This can develop in two directions: 
(i) a cellular response mediated by the T-helper 1 (THl) subset of CD4+ cells and CD8+ T cells 
which secrete pro-inflammatory cytokines to activate macrophages and enable intracellular 
killing, or (ii) a hum oral response mediated by CD4+ TH 2 cells which secrete anti-
inflammatory cytokines to de-activate macrophages and promote the differentiation and 
expansion of B cells into antibody expressing plasma cells. 
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1.2 The Immune Response to Mycobacterium tuberculosis 
Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is responsible for 1.5 million 
deaths per year worldwide and has reached epidemic proportions in southern Africa 
exacerbated by immunodeficiency secondary to HIV/ AIDS infection. Phagocytes activated by 
T lymphocytes and cytokines (eg. IFNy, TNFa and IL-12) usually control this infection in 
most people, but in 10% of infected subjects, re-activation of latent infection results in active 
tuberculosis (1 ). To develop a vaccine against this major killer, a better understanding of the 
protective immune response is required. 
Tuberculosis is contracted by the inhalation of droplets containing bacilli into the airways and 
alveolar spaces in the lungs (2). Once the bacillus is deposited onto the pulmonary epithelial 
surface of the alveoli, it is usually engulfed by an alveolar macrophage, which transports the 
pathogen into the lung parenchyma and draining lymph nodes. Following phagocytosis by the 
host macrophage, M tb resides in a phagosome in which it begins to replicate, and is able to 
survive by retarding phagolysosome formation (3). Mtb-derived proteins are shuttled through 
the endosomic pathway, degraded, and peptides thereof associate with MHC class II 
molecules. Peptide-MHC II complexes are subsequently exported to the cell surface and 
presented to antigen-specific CD4+ T cells. The infected macrophage secretes a milieu of 
effector molecules, including cytokines and chemokines, which promote the recruitment of 
additional blood monocytes and neutrophils. Eventually, lymph node-derived CD4+ T cells 
and natural killer (NK) cells traffic to the inflammatory foci. Macrophage-derived Interleukin-
12 (IL-12) and appropriate antigenic priming results in the clonal expansion and 
differentiation of antigen-specific THI CD4+ T cells (4). These activated T cells and NK cells 
secrete interferon-gamma (IFN-y) which activate tuberculostatic macrophages and augment 
antigen presentation by enhancing MHC II expression. Activated macrophages secrete tumour 
necrosis factor alpha (TNFa), which in synergy with IFNy induces the release of 
mycobacteriocidal reactive nitrogen intermediates (RNI) including nitric oxide (NO) which 
has potent anti-microbial activity. TNFa has also been shown to enhance recruitment of cells 
by upregulating vascular adhesion molecule (5). Inability of the macrophage to fully eliminate 
the pathogen leads to the development of granuloma structures, which suppress the replication 
of the bacilli (6). These structures comprise a central core of activated macrophages, 
epithelioid cells and multinucleated giant cells surrounded by CD4+ T cells. Mtb-derived 
proteins have also been shown to access the MHC I pathway as a consequence of (i) escape 
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from the phagosome into the cytoplasm (7) or (ii) translocation of mycobacterial proteins into 
the cytoplasm during persistent replication. This mechanism results in lysis of the infected 
macrophages by MHC I-restricted CD8+ cytotoxic T cells, release of the bacilli and 
subsequent phagocytosis by newly immigrated and freshly activated macrophages (8). 
1.3 Pattern Recognition of Pathogens by Antigen-Presenting Cells 
Once a pathogen has succeeded in penetrating the physiologic barriers of the host, it is 
essential that the innate immune response be rapidly induced and focused in instructing 
acquired immunity. It is equally important, however, that the immune response is induced 
upon exposure to microbial-derived antigens and not upon the recognition of self-antigens, or 
innocuous, non-self antigens (9). Induction of the acquired immune response depends on the 
expression of co-stimulatory molecules and cytokines by antigen presenting cells (APCs). The 
mechanisms that control the initial induction of these signals are not well characterised. It has 
been suggested that cells of the innate immune system detect the presence of an infection by 
means of evolutionarily selected receptors that recognise highly conserved molecular patterns 
shared by broad classes of pathogens (10). These receptors have been termed Pattern 
recognition Receptors' (PRRs) and the molecular signatures they recognise 'Pathogen 
Associated Molecular Patterns' (PAMPs) (refer to fig. 1.1 and fig. 1.2). PRRs appear to be the 
elusive link between the detection of an infection and the instruction of the subsequent 
acquired immune response. 
Fig. 1.1: Detection of a pathogen by its molecular signature (PAMP), initiation of an innate immune 
response, and instruction of the acquired immune response. (From Medzhitov et al. 2000) 
Introduction 7 
1.4 Drosophila Toll, mammalian Toll-like receptors and Innate Immunity 
The Drosophila protein toll was first described as mediating a role in the development of 
dorsoventral polarity during embryogenesis (11). Subsequently, infectious studies with adult 
Drosophila toll mutants (using flies expressing thermo-sensitive alleles of toll) revealed an 
essential role in the host antifungal response (12). Upon recognition of fungal invaders, a 
proteolytic cascade is activated, which terminates with the cleavage of the endogenous ligand 
pro-spatzle to its active form spatzle. Spatzle binds to the Drosophila toll (dToll) protein, 
which triggers an intracellular cascade terminating with a NFKB-like transcription factor 
termed dorsal. Dorsal binds upstream of the anti fungal peptide gene drosomycin, activating its 
transcription and promoting host survival. The recognition of sequence similarity between 
cytoplasmic portions of dToll and that of signalling IL-IR components (termed the toll-IL-IR 
module or TIR module) indicated that there was evolutionary conservation of pathways 
implicated in innate immunity. The first member of the mammalian toll family (named toll-
like receptors or TLR) to be identified and cloned was human Toll (hToll) based on its 
homology to dToll (13). This lead to intensive investigation in the field of mammalian TLRs, 
and to date almost ten TLRs have been cloned in mouse and man. The murine TLR4 involved 
in the recognition of the Gram-negative product LPS, and TLR2, implicated in the recognition 
of Gram-positive products, have both been observed in-vitro to be involved in response to 
Mtb. This has initiated exciting studies, which will hopefully further our understanding of the 
development of protective immunity to Mtb. 
In the context of this thesis, I investigated the role of the endotoxin receptors LBP and TLR4 
in the host resistance of mice to Mtb., therefore this review is focused on these PRRs. 
Endotoxin from Gram-negative bacteria binds to an acute phase protein, LPS binding protein 
(LBP), which has properties of a PRR (14) and enhances LPS binding to the soluble and 
membrane CD14 receptor (15). The LPS complex associates with the recently discovered 
TLR4, which is the signalling receptor, implicated in the activation of a kinase cascade. This 
cascade in turn activates the transcription factor NF-KB leading to transcription of pro-
inflammatory genes. Recently, a single amino acid mutation of TLR4 in C3H/HeJ mice was 
proposed to be responsible for their LPS resistance (16,17). This implicates TLR4 in LPS 
signal transduction. Mycobacterial cell wall components were shown to bind to the LPS 
receptor CD 14 (18, 19,20), however the role of this interaction in the induction of APCs and 
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host resistance to Mtb is not established. Utilising gene deficient mice for LBP (21), CD14 
(22), and TLR4 (23), one can determine whether the LBP/CD14/TLR4 mediated uptake and 
activation is critical for defence against M. tb infection and the induction of protective 
immunity. 
Gram-neaatiY8 Gram-positive Mycobacteria Fungi Pathogens 
bacteria bacteria 
' ' ' t LPS, BLP LTA, BLP LAM,. BLP Mannans PAMPs 
~"'~ 
TLR 
Antigen-presenting 
cell 
!Expression of cytokines, co-st imulators and chemokines I 
' Inflammation, induction of adaptive immune responses 
Currant Biology 
Fig. 1.2: Recognition of these PAMPs by TLRs on APCs activates the expression of various factors that 
lead to inflammatory responses and the induction of acquired immunity. LPS = lipopolysaccharide, BLP = 
bacterial lipoproteins, LT A= lipoteichoic acid, LAM = lipoarabinomannan (From Medzhitov et al. 1999). 
1.5 Molecules investigated in vivo in Mycobacterium tuberculosis infection 
1.5.1 Toll-like Receptor 4 (J'LR4) 
It has been well documented that the inflammatory response to LPS is initiated at the surface 
of myeloid cells by the binding of LPS to the glycosylphosphatidlyinositol (GPI)-linked 
protein CD14 (24). Since GPI-linked proteins cannot tranduce their own signals, another 
protein was speculated to be responsible for this function. Investigation of LPS 
responsiveness lead to the discovery that the C3H/HeJ mice had acquired a mutant phenotype 
through spontaneous mutations, which occurred during 1960 and 1968. (25) Genetic analysis 
established that this phenotype is under the control of a single locus named Lps on 
chromosome 4, existing in two allelic forms, Lpsn (responsive) and Lpsd (hyporesponsive) 
(26). C3H/HeJ mice were found to have a point mutation within the coding region of the Tlr4 
gene (16,17). A base transversion (C~A) in the third exon of the gene caused the substitution 
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of a histidine for an evolutionarily conserved proline at residue 712. The C3H/HeJ strain 
exhibits a remarkable tolerance to otherwise lethal doses of LPS, and several cell types, 
namely macrophages, B cells and fibroblasts are hyporesponsive to LPS in vitro. TLR4 is thus 
implicated as the early and essential part of the signal transduction machinery linking LPS 
with gene expression. The consequence of this mutation is that these mice are extremely 
susceptible to Gram-negative bacteria and succumb to an overwhelming infection (27). The 
role of TLR4 in sensing the presence of Gram-negative bacteria and triggering a lifesaving 
response is undisputed. In addition, TLR2- and TLR4-deficient mice confirm a critical role of 
TLR4 in endotoxin signalling (23) and demonstrate that TLR2, but not TLR4 is required for 
signalling by Gram-positive bacteria (28). in vitro experiments with Chinese Hamster Ovary 
(CHO) cells expressing human TLR2 or TLR4 indicated that they mediate responses to 
components of M tb and may be important in instructing the subsequent acquired immune 
response (29). These findings implicate both TLR2 and TLR4 in the recognition of Mtb-
derived PAMPs. 
1.5.2 Lipopolysaccharide Binding Protein (LBP) 
LBP is synthesised in hepatocytes as a single polypeptide and released into the blood as a 60 
kDa glycoprotein (30). The synthesis of LBP is under the control of cytokines and steroid 
hormones, and it behaves as an acute phase protein (31 ). LBP catalyses the removal of LPS 
monomers from aggregates or bacterial membranes (refer to fig. 1.3) and transfers them to 
CD14, thereby enhancing the sensitivity of cells to LPS (32). LBP mutants were generated by 
disruption of the murine LBP gene locus by targeted homologous recombination in embryonic 
stem (ES) cells (21 ). Serum from animals homozygous for the mutation had no measurable 
LBP, and were found to be hyporesponsive to the co-administration of D-galactosamine and 
LPS intra-peritoneally. As seen with the C3H/HeJ mice, the inability to respond to LPS 
renders the LBP mutants highly susceptible to infection with Gram-negative bacteria such as 
Salmonella typhi (21 ). Experiments with human microglia indicated that M tb uptake was 
mediated by CD14, and that the addition of LBP enhanced this process (33). Evidence that 
TLR4 is involved in both the recognition of Gram-negative bacteria and M tb might indicate 
that P AMPs expressed on these organisms have similar structural patterns enabling the 
engagement of the same PRR. However, it was recently demonstrated that TLRs may be 
involved in the recognition of chemically unrelated P AMPs (28), adding another level of 
complexity to TLR biology. Since TLR4 is involved in the recognition of both endotoxin and 
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Mtb PAMP(s), we hypothesised that LBP may also mediate a role in the recognition and 
transfer of these P AMP( s) during a M tb infection. 
• 1, •1. 
••• 1, 1, 
•1. •1.. ...... • • • + 
1, -c'L 
...... ...... 
•• 
•1. 
11, 11, 1, 
11, 
Macrophage Activated 
Or Neutrophil Macrophage 
Or Neutrophil 
I· LPS 1. LBP 11. LPS-LBP C..., CD14/TLR4 I 
Fig. 1.3: Mechanism of LPS stimulation of CD14-expressing cells. Signal transduction is initiated by TLR4 
and results in the potent transcription of pro-inflammatory genes. 
1.6 Additional molecules measured during the Mtuberculosis infection 
1.6.1 Interferon gamma (IFNy) 
IFNy is a cytokine which plays a major role in the immune response to Mtb. Secreted mainly 
by Thl CD4 cells and NK cells, it strongly primes for the development of the Thl subset of 
cytokines, and serves as a potent activating stimulus for macrophages. IFNy elicits 
bacteriacidal mechanisms including ROI, RNI, lysosymes and defensins (34). Mice 
genetically deficient for IFNy display dramatically impaired production of antimicrobial 
products and reduced surface expression of MHC II molecules on macrophages. IFNy-
deficient mice succumb to a sub lethal dose of the intracellular pathogen Mycobacterium bovis 
demonstrating the essential role mediated by this cytokine during mycobacterial infections 
(35). 
1.6.2 Interleukin 12 (IL-12) 
IL-12 is a pro-inflammatory cytokine produced by phagocytic cells, B cells and other antigen-
presenting cells. It mediates a critical role in bridging the innate and acquired immune 
response by inducing IFNy production of T- and NK cells, and it promotes the development 
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of the THI subset ofT cells (4). IL-12 is a heterodimeric protein (IL-12p75) comprised of two 
disulfide-linked subunits designated p35 and p40, which are encoded by unrelated genes (36). 
Both subunits can be induced by IFNy (37). The secretion of IL-12p35 is the limiting factor 
for biologically active IL-12, and homodimers of the IL-12p40 subunits can serve as 
functional antagonists (4). Mice deficient for IL-12p40 displayed dramatically reduced 
protective immunity to Mtb, and succumb to infection (38). 
1.6.3 Tumour necrosis factor alpha (TNFa) 
TNFa is a cytokine, which is a potent mediator of inflammatory reactions and tissue damage. 
It is involved in the induction of fever symptoms, the acute phase response and enhancement 
of vascular permeability (5). An essential role for TNFa in mediating protection against 
mycobacterial infections has been demonstrated with TNFa-deficient mice, which succumb 
to infection. These mice have impaired development of granulomata (39,40) which suggests 
an essential role for TNFa in the development of these structures. 
1.6.4 Monocyte chemoattractant protein 1 (MCP-1) 
MCP-1 is a CC chemokine that attracts monocytes, memory T cells, and NK cells (41) . 
Elevated levels of chemokines, including MCP-1 has been observed in bronchoalveolar 
lavage fluid of tuberculosis patients, suggesting an important role in the recruitment of 
inflammatory cells during infection ( 42). 
1.6.5 Nitric oxide (NO) 
NO is a potent RNI induced synergistically by IFNy and TNFa. (43). NO and L-citrulline are 
generated by the metabolism of L-arginine, a reaction catalysed by the enzyme inducible 
nitric oxide synthase (iNOS). NO is a potent antimicrobial agent, which has been 
demonstrated to be essential for protection against mycobacterial infections. Mice deficient 
for the enzyme iNOS2 succumb readily to infection with mycobacteria ( 44). 
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1. 7 Objectives 
The aim of this study was to investigate the role of PRRs, namely TLR4 and LBP in vivo in 
the development of an immune response to a Mycobacterium tuberculosis infection. Mice 
with null mutations of the endotoxin receptors LBP and TLR4 were compared with wild-type 
mice (PRRs intact) in the context of an aerosol Mtb infection. 
The following questions were posed: 
Are the PRR-disrupted animals more susceptible to M.tuberculosis infection? 
What role do these PRRs play in inflammatory processes and in the development of 
granuloma? 
What role do the PRRs play in driving cytokine and chemokine response? 
Specifically, the following mice were infected aerogenically with Mtb H37Rv to further 
investigate their roles in vivo in mounting an effective immune response: 
C3H/HeN and C3H/HeJ (TLR4 mutant) 
LBP+/+ and LBP-/-
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2. Materials and Methods 
2.1 Mouse Strains 
Mice were bred and maintained under specific pathogen free (SPF) conditions in the animal 
unit at the University of Cape Town, South Africa. The animals were housed in filter-top 
cages and supplied with sterile water and food ad libitum. 
Table 1: Mouse strains used in this study 
Strain WT background Reference 
€3H/HeJ C3H/HeN Charles Rivers Lab. 
LBP -/- BALB/c x 129 SV BALB/c +/+ Jack et al (21) 
2.1.1 Geno typing of Gene-deficient Mice 
The polymerase chain reaction (PCR) was performed routinely to confirm the genotype of all 
gene-deficient mice used in experiments. This method entails the amplification of DNA 
fragments, which have a known disruption. 
2.1.2 Phenotyping of TLR4 mutants C3H/HeJ 
The natural mutant C3H/HeJ, which has a single point mutation, was phenotyped by its 
hyporesponsiveness to lipopolysaccharide (LPS) using two approaches. 
In vivo: Mice were injected intra-peritoneally with 500 µI LPS (200µg/ml) (E.coli Serotype 
0111:B4, Sigma)/ PBS using a 0.5 cc syringe 29 gauge needle (Braun) or 500 µI PBS. Blood 
was collected from the retro-orbital (RO) plexus using a non-heparinised capillary tube 
(2x?5mm, Superior) under diethyl-ether anaesthesia at the peak of TNFa production (ie. 90 
mins post administration). 
Ex vivo: Animals were bled via the RO plexus (200µ1), and the heparinised (Pharmacare 
Limited) whole blood split into 2 parts. Each part was mixed and incubated with an equal 
volume of either PBS/heparin (4U/ml) or PBS/LPS (50ng)/heparin (4U/ml) for 4 hours at 
37°C. Serum and supernatant TNFa concentrations were measured by a TNFa-specific 
sandwich ELISA. 
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2. 1.3 Tail digestion 
5 mm tail sections were taken under sterile conditions and digested o/n at 56°C in 1.5 ml 
eppedorf tubes containing 750 µl lysis buffer [50mM Tris-HCl [pH8], lOOmM EDTA, 
lOOmM NaCl, 1 % SDS, 0.5mg/ml Proteinase K (20mg/ml)]. 
2.1.4 DNA extraction from mouse tails 
Protein was precipitated from lysates by adding 250µ1 of a saturated NaCl (6M) solution. This 
was mixed briefly in an eppendorf shaker and centrifuged in a microfuge at 14000 rpm for 5 
mins. 750µ1 of supernatant was transferred to a new eppendorf containing 300µ1 chloroform, 
mixed and centrifuged at 14000 rpm for 30 secs. The upper phase was taken and DNA 
precipitated by adding 0.6 Vol. cold isopropanol (-20°C). This was centrifuged at 14000 rpm 
for 5 mins, and the pellet washed with 0.5ml 70% ethanol by vortexing and subsequent 
centrifugation (5 mins, 14000 rpm). Pellets were dried in a 37°C incubator and dissolved in 
0.5ml ddH20 at 37°C. DNA solutions were stored at -20°C until further use. 
2. 1. 5 PCR reactions 
The PCR reactions were carried out in thin walled 0.2ml 8-strip PCR tubes in a PTC 200 
Peltier Thermocycler (MJ Research, Massachusetts, USA). 
Table 2:Standard PCR Reaction Mix (xl): 
DNA sample 2µ1 
1 Ox Taq Buffer 5µ1 
DNTP (2.5mM, Promega) 4µ1 
Primer 1 (6.25µM) 2µ1 
Primer 2 (6.25µM) 2µ1 
Taq (5U/µl) 0.05µ1 
ddH20 34.95µ1 
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Primers for use in PCR reactions were synthesised at the Department of Biochemistry, 
University of Cape Town. 5µ1 loading buffer (0.25% bromophenol blue, 0.25% xylene 
cyanol, 50% glucose) was added to 25µ1 of the amplified products. These were separated by 
electrophoresis on 1.6% agarose gel (Whitehead Scientific Dl LE) in TBE buffer (44.5mM 
Tris, 44.5mM boric acid, lmM EDTA), buffer containing 0.4ml ethidium bromide/ lOOml 
(1 Omg/ml) . Bands were visualised using the Gel Doc system (Biorad) and Multianalyst 
software (Microsoft). 
PCR to genotype LBP-/- mice: 
Primers: 
P l: 5 AgA ggC Atg gTg gCC AgA 3 
P2: 5 CCC ACT CCT ggg CTT TgT 3 
N I: 5 CTg AAT gAA CTg Cag gAC gA 3 
N2: 5 ATA CTT TCT Cgg Cag Gag CA 3' 
Pl + P2 amplify the region flanking the Neo cassette 
N l + N2 amplify a region within the Neo cassette 
Thermocycling conditions: 
1. 94°c 30 
2. 61 °C 30 
3. 72°C 30 35X 
PCR products: 
WT band (Pl + P2) = 195 bp 
KO band (Pl + P2)= 465 bp 
Neo band (NI + N2) = 172bp 
(As we were unable to amplify the larger LBP-/- band, we utilised a Neo PCR in combination 
with the detection of the LBP WT fragment.) 
Table 3: Expected result after LBP/Neo PCR 
PCR reaction LBP +/+ LBP+/- LBP -/-
LBP WT (195) + + -
Neo (172 bp) 
- - + 
Materials and Methods 16 
2.1. 6 Detection of Cytokine and Chemokines by ELISA 
The concentration of the cytokines IL-12, IFNy and TNFa, and the chemokine MCP-1 were 
determined using sandwich ELISA (Enzyme Linked Immunosorbent Assay). 
96 well microtiter ELISA plates (Maxisorp [NUNC]) were coated with 50µ1 appropriate 
coating antibodies (see appendix B), diluted in dilution buffer (0.1 % BSA/PBS/.02% 
sodium azide [Merck]) and incubated at 4°C / o/n. Plates were washed three times with PBS 
and incubated with 150µ1 blocking buffer ( 4% BSA/PBS/0.04% sodium azide) for 2 hrs at 
37°C to block residual binding sites on the plastic. Plates were next washed 4x with washing 
buffer (0.05% Tween20 [Sigma], PBS, 0.01 % sodium azide) and incubated with 60µ1 of 
samples diluted 3-fold in dilution buffer and 60µ1 appropriate cytokine standards included in 
12 three-fold dilutions. This step was incubated o/n at 4°C, plates washed as before and 
incubated with 100µ1 of a capture antibody (see appendix) for 2 hrs at 37°C. After washing, 
either 100µ1 streptavidin-alkaline phosphatase (1/1000) (for biotinylated secondary 
antibodies) or an alkaline-phosphatase conjugated antibody was added for 1 hr at 3 7°C. Plates 
were developed by incubating with 100µ1 p-nitrophenylphosphate (Boehringer Mannheim, 1 
mg/ml in Diethanolamine buffer, see Appendix) and read at 405/492 nm in a microtiter 
spectrophotometer (Organon, Technika). To stop reactions 50µ1 lM NaOH was added. 
2.2 Preparation of Infective Mycobacterium tuberculosis 
2.2.1 Cultivation 
Mycobacterium tuberculosis H37Rv was obtained from Prof. G Kaplan, Rockefeller 
University NY. A sample was removed from a Lowenstein-Jensen slant using a sterile plastic 
disposable inoculating loop, and deposited into a 50ml sterile screw-capped tissue culture 
flask (Greiner labortechnik) containing 10 ml of Middlebrook 7H9 Broth [Difeo]/ 10% 
OADC enrichment medium (State Vaccine Institute, Cape Town). Culture flasks were 
incubated at 37°C in a CO2 incubator and shaked daily to gently agitate the broth. Incubation 
proceeded for 1-2 weeks until the culture was very turbid (CFU density of 5x 107 to 5x108/ 
ml) and in the mid-late log growth phase. 
20 ml from this culture was carefully transferred into a 250 ml sterile screw-capped culture 
flask (Greiner labortechnik) containing 90 ml Middlebrook 7H9 Broth [Difeo]/ 10% OADC 
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enrichment medium. These culture flasks were further incubated for 1-2 weeks at 37°C in a 
CO2 incubator and shaked daily until a similar turbidity was attained. 
Aliquots of these mid-late log phase cultures were aseptically prepared by pipetting 1 ml 
per vial into sterile 2 ml serum vials (Greiner). These aliquots were place into a storage box 
within a -70C: freezer until further use. 
2.2.2 Inoculum Determination- Colony Forming Unit (CFU) 
The concentration of bacilli was determined by making 10-fold serial dilutions in 0.9% NaCl/ 
0.04% Tween 80, and plating out dilutions of 10-2 to 10-7 on Middlebrook 7Hl0 Agar (1.9% 
7Hl0 Agar [Difeo], 0.5% glycerol, 10% OADC [oleic acid, dextrose) on 2 compartment 
plates (90mm Plates, Sterilin). These were incubated at 37°C for 15-18 days and colonies 
counted using an inverted microscope (Wild M8 Heerbrugg). 
2.3 Aerosol Infection of Mice 
2.3.1 Preparation of Inoculumfor Aerosol Infection 
An established procedure was followed when preparing the inoculum (Robert and Orme, 
1999). An aliquot of M tb was thawed at room temperature, centrifuged at 4000rpm for 5 
mins, and resuspended in a total volume of 6ml 0.9% Saline. The inoculum was sonicated on 
level 1-2 (4x 5 secs. on/off cycles) to disrupt clumping. To obtain the desired rate of infection, 
the inoculum was prepared 5 log1o CFU higher than one required delivered into the lungs of 
the animals (the aerosol machine is programmed to deliver into the lungs approximately 5 
log10 CFU lower than the inoculum nebulised) ie. to obtain 100 CFU/lungs, the mycobacterial 
suspension was prepared at 2.0x 106 CFUs/ml in a total volume of 6ml sterile 0.9% saline 
(1.0xl07 CFU/5ml nebulised) To confirm the inoculum, 10-fold serial dilutions from 10-1 to 
10-7 were prepared and plated on Middlebrook 7Hl0 agar. 
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2.3.2 Aerosol Procedure 
The aerosol exposure chamber (Middlebrook) was sterilised prior to use with a 3% virkon 
solution followed by 70% ethanol. The metal basket support/baffle plate and stainless steel 
mesh exposure basket was placed into the chamber drum. The divisions within the drum were 
labelled appropriately with the mouse strain, and the mice transferred from their cages into 
the basket (sexes separated). The basket lid was secured and the perspex chamber lid sealed 
by firmly snapping the latches. After sealing the chamber, the glass Nebuliser-Venturi was 
mounted to the compressed air and main air flow fittings, which was secured by 3 clamps. A 
safety mask was placed over the face for the rest of the procedure. Carefully, the screw cap on 
the nebuliser was removed and 5ml of the inoculum added into the bottom of the venturi 
using a 5ml syringe fitted with an 18-gauge needle. After screwing the lid closed, the 
instrument was switched on including the UV lamp and computer. 
The program to be entered for aerosolising mice was as follows: 
(i) Preheating time 15 minutes 
(ii) Nebulising time 40 minutes 
(iii) Cloud decay 40 minutes 
(iv) Decontamination 15 minutes 
The preheating time is to enable the incinerator to achieve its core temperature of 790°C in 
order to decontaminate the exhaust air. During the nebulisation cycle the compressed air is 
activated and passes through the venturi of the nebuliser to create droplet nuclei containing 
bacilli. These droplet-nuclei are carried into the chamber containing the animals. The third 
cycle is cloud decay in which the aerosol chamber is purged with fresh air and the bacterial 
mist dissipated. During the final cycle the UV lamps are switched on to decontaminate the top 
surfaces of the basket. Once the instrument had initiated the Preheat cycle , the Main Air 
Flowmeter should indicate 60 cubic feet/hour (CFH), and adjusted with the control valve if 
necessary. 
When the nebulising cycle starts, the Compressed Air Flowmeter should be at 10 CFH, and 
adjusted if required. The room containing the chamber was then vacated until the process 
ended (110 minutes), and the door appropriately marked to prevent intrusion. After 
completion of the cycle, the instrument was switched off, the lid opened, and the mice 
returned to their cages. All the contaminated components were wrapped up, sterilised by 
autoclaving, scrubbed clean and then autoclaved once more. 
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2.3.3 Determination of Initial Pulmonary Infection (Day 1) 
To determine uptake of mycobacteria into the lungs of the mice, 5 animals were sacrificed by 
cervical dislocation one day after aerogenic challenge. Entire lungs were removed and 
immediately placed into sterile tubes containing 1ml of 0.9% NaCl/0.04% Tween80 solution. 
After all necropsies were completed, individual lungs were transferred into sterile 10ml 
perspex mortar and homogenised with a pestle secured in a drill (Black and Decker 
KD574CRE, 680W). Lung homogenates were plated in duplicate volumes of lOOul and 200ul 
on Middlebrook 7H10 agar in duplicate, incubated at 37°C for 15-18 days, and CFUs 
enumerated. 
2.4 Phenotypic Analysis 
2.4.1 Mortality Studies 
To assess the susceptibility of mice, groups of 5-10 sex-matched mice between the age of 8-
12 weeks were challenged aerogenically with Mtb H37Rv. Mice were sacrificed as in 2.3.3 to 
determine the initial pulmonary infection. Animals were monitored regularly and weighed on 
a weekly basis to assess the progression of the disease. Animals succumbing to infection were 
discarded and the time post-infection recorded. 
2.4.2 CFU determination in organs 
To determine the growth of the mycobacteria in the animals, groups of 3-4 mice from each 
group were sacrificed at various time points. Livers, spleens and lungs were removed and 
immediately placed into sterile tubes containing 4ml of 0.9% NaCl/ 0.04% Tween80 solution. 
After all necropsies were completed, individual organs were transferred into sterile 10 ml 
perspex mortar and homogenised with a pestle secured in a drill (Black and Decker 
KD574CRE, 680W). lOOul of organ homogenates were plated in duplicate on Middlebrook 
7H10 agar, incubated at 37°C for 15-18 days, and CFUs enumerated 
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2.4.3 Histology of Paraffin Wax Embedded Tissue 
A section of the liver, spleen and lung was removed from each mouse sacrificed, and placed 
immediately in a solution of 4% buffered Formaldehyde (Merck). These sections were left in 
solution for 2 days to ensure killing of bacilli. Sections were then processed o/n, embedded in 
paraffin wax, and cut to 2µm with a microtome . 
2.4.3.1 Haematoxylin and Eosin staining (HE) 
Tissue sections were dewaxed o/n by incubating at 56°C in an oven. The next day, tissue 
sections were rehydrated by passing them sequentially through: 2x xylol, 2x 100% ethanol, 2x 
96% ethanol, 2x 70% ethanol, and ddH20. Slides were placed in a haematoxylin solution for 
8 minutes and then washed in ddH20 for 1-2 minutes. The excess staining was removed by 
immersion in 1 % acid alcohol for 10 seconds, and the blue colour retrieved by leaving the 
slides in ddH20 for 30 minutes. The slides were next placed in 1 % eosin for 2 minutes, 
washed in ddH20, and dehydrated by passing through 2x 10% ethanol, 2x 96% ethanol and 
2x 100% ethanol. The sections were finally immersed in xylol, mounted with Canada Balsam, 
and covered with a coverslip. 
Materials 
Mayer s Haematoxylin 
lg haematoxylin 
50g ammonium ( or potassium alum) 
0.2g sodium iodate 
1 g citric acid 
11 ddH20 
Acid alcohol 
1 % HCl in 70%ethanol 
2.4.3.2 Ziehl-Neelsen Staining (ZN) 
Tissue sections were dewaxed o/n by incubating at 56°C in an oven. The next day, passing 
them sequentially through 2x xylol, 2x 100% ethanol, 2x 96% ethanol, 2x 70% ethanol, and 
ddH20 rehydrated sections. Slides were placed on a staining rack and flooded with 6% carbol 
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fuschin, flamed until steaming and then left for 5 minutes. The flaming-cooling step was 
repeated as before, and followed by a washing step in ddH20. Sections were rinsed in 1 % acid 
alcohol until excess colour removed, washed in ddH20, and immersed in 25% H2S04 for 20 
minutes. Slides were washed in running ddH20 for 10 minutes to remove acid and 
counterstaining was performed in Loeffler s methylene blue for 30 seconds. Sections were 
washed a final time, dehydrated through to xylol and mounted in Depex mounting medium 
(Merck). 
Materials 
Carbol Fuschin Solution 
A 6% stock solution of carbol fuschin is prepared in 100% alcohol. For use in staining, 10 ml 
stock carbol fuschin is added to 90 ml phenol and filtered. 
Loeffler s Methylene Blue 
A stock solution is prepared by dissolving 0.8% methylene blue in 100% alcohol. For use in 
staining, 30 ml stock solution and 1 ml 1 % potassium hydroxide (in ddH20) were added to 99 
ml ddH20. The solution was filtered before use. 
2.4.3.3 Antigen retrieval and Immunohistochemistry (IHC) 
To expose the epitopes masked by the paraffin wax, a retrieval method was utilised. Slides 
were incubated o/n at 56°C to melt the wax and the following day rehydrated by passing 
through 2x 100% ethanol, lx 96% ethanol, 2x 70% ethanol and ddH20. To demask the 
epitopes, sections were microwaved in citrate buffer on medium setting for 2x 5 min., and 
then left in the buffer to cool to room temperature for 20 min. Sections were next fixed in 
acetone for 10 min., followed by 15 min. air-drying. Endogenous peroxidase activity was 
blocked by incubating in 1 % H20 2/ methanol for 30 mins, followed by a wash with lx PBS. 
To block endogenous biotin, sections were incubated in 0.1 % avidin for 30 min., avidin 
shaken off, and then incubated in 0.01 % biotin for 20 min. Blocking was performed for 30 
min. in 1.5% serum/ PBS, serum shaken off and sections incubated o/n at 4°C with 50µ1 of 
the primary antibody at a previously determined concentration. The following day, sections 
were washed with lx PBS and incubated with the appropriate secondary antibody for 30 
mins. ABC vector kit was added to the sections for 30 min., followed by a washing, and then 
a 10 min. incubation with the DAB substrate (1ml buffer to 1 drop chromagen) (Dako). 
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Sections were washed in running ddH20, incubated in 1 % CuS04 for 2 min. and then washed 
again for 2 min. in running ddH20. Sections were counterstained in Mayer s haematoxylin for 
4 min. and washed in running H20. Sections were dehydrated by passing through 2x 70% 
ethanol, lx 96% ethanol, 2x 100% ethanol, 2x xylene. Finally, sections were mounted in 
Entellen and covered with a coverslip. 
Materials 
Entellan (Merck) 
Citrate buffer pH 6: 
Solution A- 1.05g citric acid in 50ml ddH20 (O.OlM) 
Solution B- 2.94g sodium citrate in 100ml ddH20 (O.lM) 
Working solution - 9ml A + 41 ml B in 500ml ddOO 
2.4.4 Bronchoalveolar Lavage (BAL} 
2.4.4.1 Quantification of cytokine/chemokine levels in BAL fluid 
Mice were administered a lethal dose of anaesthetic intra-peritoneally (50mg/ml Ketamine 
hydrochloride/ 2% Rompun). The mouse to be lavaged was then pinned to the dissecting 
board, and its trachea exposed in a sterile manner by making a small incision in its neck. The 
skin, fatty tissue and salivary gland was carefully cut away, trying to avoid severing the 
surrounding blood vessels. The membrane surrounding the trachea was removed and to 
support it, a 21-gauge needle inserted from the underside. The dissecting board was elevated 
to ensure flow of lavage fluid into the lungs. A 22 gauge cannula (Introcan 0.9x 25mm, 
Braun) was inserted into the trachea, and when firmly in place, the needle removed from the 
cannula. A 1 ml syringe was attached to the end of the cannula, and the lungs lavaged twice 
with 350µ1 of ice cold PBS solution (5 aspirations). The lavage fluid recovered was placed in 
an eppendorf tube and stored on ice. The lungs were lavaged a further 3 times with 900µ1 PBS 
(5 aspirations), and the fluid recovered placed in 14ml conical tubes (Sterilin). The lavage 
fluid in the eppendorfs was centrifuged at 2000 rpm for 5 mins, and 100µ1 aliquots of the 
supernatant prepared. These aliquots were stored at -70C: until further use. For the detection 
of cytokines/ chemokines, appropriate aliquots were thawed and used in sandwich ELISAs as 
described above in 2.1. 6. 
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2. 4. 4. 2 Differential count of cells in BAL fluid 
The conical tubes containing the remaining BAL fluid was centrifuged at 2000 rpm for 5 
mins, the cell pellet obtained, pooled with the eppendorf pellet, and resuspended in a total 
volume of 1 ml. Viable cell numbers were counted with trypan blue (1: 1 ), (0.4%, Sigma), 
diluted to 2-3x 105 cells/ml, and duplicate 50µ1 volumes placed in 8 well teflon coated 
microscope slides (6mm, Highveld Biological). The slides were left at room temperature to 
air-dry, stained with the RapiDiff kit (Clinical Sciences Diagnostics) by immersing the slides 
briefly in RapiDiff fixative, Rapidiff solution 1 (Eosin in Phosphate Buffer), RapiDiff 
Solution 2 and a final rinse with ddH20. Differentials were assessed after placing a coverslip 
over the slide. Cell percentages were determined by counting 100 cells/well, (n=4 mice per 
group). The cell free supernatant was frozen for cytokine or chemokine ELISA 
determinations. 
2.4.5 Quantification of Cytokine/ Chemokines in lung homogenates 
Mice were sacrificed, entire lungs removed, and an equal lung mass placed in 1ml of ice cold 
PBS solution. The contents were transferred into sterile 10 ml perspex mortars (kept on ice) 
and homogenised with a pestle (4x 10 second cycles) using the Black and Decker Drill on 
high (setting of six). Homogenates were centrifuged at 14000 rpm, supernatants aliquotted in 
100µ1 volumes, and stored at -70C until further use. Prior to use in ELISA, aliquots were 
thawed, centrifuged at 14000 rpm, and the supernatants used for cytokine/ chemokine 
quantification. 
Results 
3. Results 
3.1 The Role ofTLR4 in the Host Immune Response to a Mtuberculosis Infection 
3.1.1 Phenotyping the TLR4 mutant C3H!HeJ 
The TLR4 mutant was phenotyped by its hyporesponsiveness to LPS in vivo and ex vivo. 
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Fig. 3.1:Measurement ofTNFa. production in response to LPS (n=4 mice/ group) 
A: (in vivo): TNFa. measured 90 min. following administration of lOOµg LPS i.p 
B: (ex vivo): TNFa. measured in supernatant of whole blood cells stimulated with SOng LPS (4 hrs, 37°C) 
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( ~ P < 0.05). (PBS administered as a negative control resulted in no detectable levels of TNFa. (data not 
shown)). 
The C3H/HeN mice, which have the wild-type allele of the TLR4 gene, display the classical 
in vivo symptoms of endotoxic shock in response to LPS (ie. weight loss, ruffled coat, 
diarrhoea, immobility and mortality). The substantial production of TNFa in response to LPS 
was observed in the C3H/HeN mice, but not in the C3H/HeJ mice (in vivo Fig. 3.IA). The 
C3H/HeN-derived whole blood (WB) cells are acutely sensitive to LPS and release an ample 
amount of TNFa in response (ex vivo Fig. 3.IB). The C3H/HeJ mice, which have a mutant 
allele of the TLR4 gene are protected from the endotoxic shock and do not manifest any of 
the symptoms that afflict the C3H/HeN mice. Surprisingly, the C3H/HeJ mice do produce 
TNFa in response to LPS, but at a level much lower than the C3H/HeN mice (Fig. 3.IA) 
This apparent responsiveness by the C3H/HeJ mice to LPS is probably due to trace amount of 
contaminants in the LPS/ PBS solution (personal communication with C.Galanos). 
This hyporesponsiveness to LPS is confirmed ex vivo by the diminished production of TNFa 
by C3H/HeJ-derived whole blood cells (Fig.3.IB). These results confirm the phenotype of the 
C3H/HeJ mice. 
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3.1.2 Mortality of the Tlr4 mutant C3H/HeJ 
To assess the susceptibility of the TLR4 mutants to an Mtb infection, 5 female C3H/HeN and 
C3H/HeJ mice (8-12 weeks old) were challenged aerogenically. The mice were monitored 
regularly, weighed weekly and mortality was recorded. 
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Fig. 3.2: (A) Mortality study of C3H/HeN mice vs. C3H/HeJ mice infected aerogenically with M.tb H37Rv 
(dosage at dayl = 50-100 CFU/lung, n=S mice/ group). (B) Mean weight of C3H/HeN vs. C3H/HeJ mice 
during the infection (n=S mice/ group). 
Only one of the C3H/HeN mice succumbed to the infection up to the time observed, whereas 
the C3H/HeJ mice slowly deteriorated and all eventually died between 5 and 7 months (Fig. 
3.2A). The mean weight of the C3H/HeJ mice, which was slightly greater than the C3H/HeN 
mice initially, decline from day 146 (Fig. 3.2B), concomitant with these mice succumbing to 
M tb infection. 
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3.1.3 CFU study ofT/r4 mutant C3H/HeJ 
To investigate the progression of the disease with respect to the mycobacterial load, livers, 
spleens and lungs were removed and CFU assays performed. 
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Fig. 3.3: Mycobacterial load assessed in the liver (A), spleen (B) and lungs (C) by CFU assay. Data 
expressed as the mean number of viable bacteria, and standard deviations indicated with the vertical bars. 
(n= 3-4 mice/ group, -:r p<0.05,;,-~ p<0.01 using the Student's t-test). 
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The initial exposure of these mice was determined to be approximately 100 CFU/ lungs at day 
one. CFU was not detectable in the liver and spleen at day one (data not shown). Fig. 3.3 
demonstrates that the C3H/HeN mice were able to control the Mtb infection in the liver, 
spleen and lungs. The number of viable bacilli in the lungs decline gradually two months 
post-infection, and insignificant growth is noted extra-pulmonarily. In contrast to this, the 
C3H/HeJ mice appear to be impaired in their ability to control the M tb infection. The 
pulmonary infection in these two groups diverges after one month, and a significant 
progression is noted in the lungs of the C3H/HeJ mice (Fig. 3.3C). Dissemination from the 
lungs occurs at the same rate initially (at 1 month), but the effective control of infection in the 
lungs, liver and spleen of the C3H/HeN mice is clearly absent in C3H/HeJ mice (Fig. 3.3A, 
Fig. 3.3B and Fig. 3.3C). 
3.1.4 Analysis of organ weights of the CJH!HeNvs. CJH!HeJmice 
During necropsy, the masses of the liver, spleen and lungs were recorded and later expressed 
as a ratio of the respective mouse body weight (BW). These calculations give an indication of 
the developing inflammatory response with respect to cellular recruitment within the organs. 
(The average group mass remained stable for most of the experiment, thus the differences 
noted between the ratios ( organ weight/ body weight expressed as a percentage) can be 
attributed to inflammatory processes and not necessarily BW loss). 
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Fig. 3.4: Analysis of organ weights: body weight (BW) ratio in the C3H/HeN vs. C3H/HeJ mice 
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(A) liver expressed as a ratio of body mass, (B) spleen expressed as a ratio of body mass, (C) lungs 
expressed as a ratio of body weight (n=4 mice/ group, * p< 0.05, **p<0.01 using the student's t-test). 
There is no significant difference between the ratios of the liver (Fig. 3.4A) and the lungs 
(Fig. 3.4C), but the spleen of the C3H/HeJ mice are significantly more inflamed than those of 
the C3H/HeN mice (Fig. 3.4B) 
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3.1.5 Histological analysis of C3H HeN and C3H HeJ mice infected with M tuberculosis 
Fig 3.5: Microscotlic alterations in lungs of C3H/HeN (left panels) and C3H/HeJ mice (right panels) 
28 days (A, B) and 140 days (C, D) post aerosol Mtb infection using HE stain (histology performed on 
2 sections per mouse, 3-4 mice per grout)) 
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The Haematoxy lin and Eosin (HE) stain revealed that there was comparable inflammation at 28 
days post-infection in the lungs of the C3H/HeN mice (Fig. 3.5A) and the C3H/HeJ mice (Fig. 
3.5B), but a more prominent neutrophil presence in the C3H/HeJ lungs. At 140 days post-
infection, more congestion was noted in the lungs of the C3H/HeJ mice (Fig. 3 .5C) resulting in 
less airspace than the C3H/He lungs (Fig. 3.5D). The level of granulomata were comparable in 
the lungs of the two groups, but an increased lung parenchymal infiltration by neutrophils was 
obser ed in the C3H/HeJ mice upon examination of histological sections (data not shown). 
0 
Fig. 3.6: ZN stain for acid-fast bacilli (A-D) and iNOS2 (E,F) in lungs of C3WHeN (left panels) and C3H/HeJ 
mic (right panel ) 28 da)·s (A,8), 1-10 da)·s (C,D) and 56 da)'S (E,F) post aerosol Mtb infection (histology 
1> 'rform d on 2 ection per mouse, 3-4 mice per group) 
Th Z stain re ealed that at 28 da s post-infection, the le el of acid-fast bacilli (AFBs was 
imilar in the two groups of mice Fig. 3.6A and Fig. 3.68 ). Howe er, at 140 days, while AFB 
w r ea ily n ticed in primaril y foamy macrophages of the C3H/HeJ lung Fig. 3.60 ), they 
w r YirtualLY undete table in the C3WHe lun2s (Fi2. 3.6C). The i OS2 tain re,·ealed 
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that at 2 months post-infection, there was no difference in the e:x.pression of iNOS2 between the 
two groups. 
Fig. 3.7: Microscopic alterations in livers of C3H/HeN (left panels) and C3H/HeJ (right 1mnels) mice 28 da)'S 
(A,B) and l~O da)'S (C,D) post aerosol Mtb infection by HE stain (histolog_,· performed on 2 sections per 
mouse, 3-~ mice per group). 
The HE stain in the liver revealed that at 28 days post-infection there were few diffuse 
granulomatous structures in the li vers of the C3H/HeN mice (Fig. 3.7A) and C3H/HeJ mice 
(Fig. 3.7B). At 140 days post-infection, there were more prominent hepatic granulomata in the 
C3H/HeJ mice (Fig. 3.7D) than in the C3H/HeN mice (Fig. 3.7C) (about fi ve-fold more 
granulomata in the C3H/HeJ livers, data not shown) . 
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3.1. 6 Analysis of BAL cells from C3H/HeN and C3H!HeJ mice 
Bronchoalveolar lavage (BAL) was performed on C3H/HeN and C3H/HeJ mice 4 weeks after 
aerogenic challenge with Mtb, BAL cells retrieved from the lavages were stained with a 
RapiDiff kit and counted to determine the type of cells recruited into the alveolar spaces. 
NaYve mice were analysed to determine the baseline levels ( data not shown). 
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Fig.3.8: Differential counts of BAL cells from C3H/HeN and C3H/HeJ mice 4 weeks into a pulmonary 
M.tb infection. (A) % macrophages in the BAL, (B) % Lymphocytes in the BAL and (C) % neutrophils in 
the BAL) (n=4 mice/ group* p< 0.05 by student's t-test). MCs = macrophages, LCs = lymphocytes, NTs 
= neutrophils. 
The aerogenic Mtb infection of these mice was determined to be 300 to 350 CFU per lungs at 
day I. The C3H/HeN mice had a significantly larger proportion of macrophages than the 
C3H/HeJ mice did 4 weeks post-infection (Fig. 3.8A), but the lymphocyte population 
appeared to be comparable (Fig 3.8B). Interestingly, there was a significant population of 
neutrophils recruited into the alveoli of the C3H/HeJ mice at this time point, which did not 
occur in the C3H/HeN lungs (Fig. 3.8C). This data concurs with the histological finding of 
increased lung parenchymal infiltration by neutrophils in the C3H/HeJ mice ( data not shown). 
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3.1. 7 Analysis of cytokine/ chemokine production in BAL fluid of C3H/HeN vs. C3H/HeJ 
mice 
Bronchoalveolar lavage (BAL) was performed on C3H/HeN and C3H/HeJ mice 4 weeks after 
aerogenic challenge with M tb. BAL fluid was analysed by ELISA to determine the 
concentration of cytokines and chemokines in the alveolar spaces. 
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Fig. 3.9: Measurement of cytokine production by ELISA in bronchoalveolar fluid (BAL fluid) at 4 weeks 
following infection with M.tb. (A) IL-12p40 (ng/ml), (B) TNFa (ng/ml). (n=4 mice/ group -ti> <0.05 using 
student's t-test) 
The production of pro-inflammatory IL-12p40 was significantly reduced in the BAL fluid of 
the C3H/HeJ mice in comparison to the C3H/HeN mice (Fig. 3.9A). The level of TNFa 
measured in the C3H/HeJ mice was also reduced, but not significantly (Fig. 3.9B). The T 
lymphocyte and monocyte chemoattractant chemokine, MCP-1, was not detectable in the 
BAL fluid at this time point ( data not shown). IFNy was also measured in the BAL fluid, and 
found to be reduced in the C3H/HeJ mice, but not significantly. 
3.1.8 Analysis ofCytokine/Chemokine Production in Lung Homogenates of 
C3H/HeN vs. C3H!HeJ 
Lungs derived from C3H/HeN and C3H/HeJ mice 4 weeks post M. tb infection were 
homogenised, centrifuged, and the supernatant analysed for the presence of cytokines/ 
chemokines. This technique enables the measurement of cytokines/chemokines produced 
within the entire lung environment, whereas BAL is restricted to measurement within the 
alveolar spaces. 
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Fig. 3.10: Measurement of cytokines/ chemokines in the lung homogenates 4 weeks post-infection 
(A) IL-12p40 (ng/ ml), (B) IFNy (ng/ ml), (C) TNFa (ng/ ml), (D) MCP-1 (ng/ ml) 
(n=4 mice/ group,u p<0.05, titip<0.01 using student's t-test). 
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The cytokines IL-12 and TNFa were significantly reduced in the lung homogenates of 
C3H/HeJ mice when compared to the C3H/HeN mice (Fig. 3.IOA and 3.IOC). 
The level of IFNy in the C3H/HeJ lung homogenates was lower than m C3H/HeN 
homogenates, but not significantly (Fig. 3. IOB). The monocyte and T lymphocyte chemokine 
MCP-1 was significantly lower in C3H/HeJ mice than C3H/HeN mice (Fig. 3.IOD). 
TLR4 appears therefore to play a significant role in the host response to Mtb infection. In the 
absence of TLR4, mice succumb to the infection with a two log higher CFU load in the liver 
and spleen, and a significantly higher lung load. Reduced resistance appears due to a reduced 
induction of pro-inflammatory cytokines. 
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3.2 Preliminary Study: The Role of Lipopolysaccharide Binding Protein (LBP) 
in Mtuberculosis Infection 
As the endotoxin response system is composed of primarily CD14, LBP and TLR4, and since 
we demonstrated the importance of TLR4 in Mtb infection, we were interested whether the 
absence of other components of this system resulted in a similar phenotype. We therefore 
investigated the role ofLBP (CD14-deficient mice were not available for this study). 
3.2.1 Genotyping of LBP-1- mice 
The LBP genotype was identified by a PCR reaction which detected the presence/absence of 
the LBP WT allele (Fig. 3.1 lA) in combination with a Neo PCR (Fig. 3.1 lB) 
Fig. 3.11: Genotyping ofLBP-/- mice. 
(A) Amplification ofLBP wild-type allele (195 hp) 
(B) Amplification ofNeo cassette (172 hp) 
Lane 1 = +/- mouse, Lanes 2-11 = -/- mice, Lane 12 = negative control 
The genetic identity of the LBP mutants was thus confirmed by PCR. 
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3.2.2 Phenotyping of LBP-1- mice 
The LBP mutants were also phenotyped by their hyporesponsiveness to LPS. As with the 
C3H/HeJ mice, this was done both in vivo and ex vivo. 
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Fig. 3.12:Measurement ofTNFa production in response to LPS (n=4 mice/ group) 
A: (in vivo): TNFa measured 90 min. following lOOµg LPS i.p 
LBP-/-
B: (ex vivo): TNFa measured in supernatant of whole blood cells stimulated with SOng LPS (4 hrs, 37°C) 
(p ,l4 < 0.01). (PBS administered as a negative control resulted in no detectable levels of TNFa (data not 
shown)). 
The LBP+/+ mice produced copious amounts of TNF a at 90 minutes in response to LPS 
challenge i.p (Fig. 3.12A), displayed the symptoms of endotoxic shock, and eventually 
succumbed. In contrast to this, the LBP-/- mice were protected from shock and produced 
insignificant TNFa in response to the LPS (Fig. 3.12A). This phenotype was confirmed by 
the ex vivo findings that the LBP-/- mice-derived whole blood cells were insensitive to LPS 
stimulation, but the LBP+/+ derived cells were LPS responsive (Fig. 3.12B). 
3.2.3 Mortality Study of LBP-1- mice 
To assess the susceptibility of the LBP-/- mice to an Mtb infection, six female LBP+/+ and 
six LBP-/- mice (8-12 weeks old) were challenged aerogenically. The mice were monitored 
regularly, weighed weekly, and mortality recorded. 
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Fig. 3.2: (A) Mortality study of LBP+/+ vs. LBP-/- mice infected aerogenically with M.tb H37Rv (dosage at 
dayl = appro. 100 CFU/lung, n=S mice/ group). (B) Mean weight analysis of LBP+/+ and LBP-/- mice 
(n=6 mice/ group). 
The LBP+/+ mice survived the duration of the experiment, but the LBP-/- mice succumbed to 
the M tb infection between 9 and 19 weeks (Fig. 3 .11 A). The average mass of the LBP+/+ 
mice remained stable, whereas the mass of the LBP-/- mice declined steadily from 9 weeks 
onwards (Fig.3.l 1B). 
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3.2.4 CFU study of LBP+I+ vs. LBP-1- mice 
To investigate the progression of the disease with respect to the mycobacterial load, liver, 
spleen and lungs were removed and CFU assays performed. 
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Fig. 3.14: Mycobacterial load assessed in the liver (A), spleen (B) and lungs (C) by CFU assay. Data 
expressed as a logarithmic value of the mean number of viable bacteria, and standard deviations indicated 
with the vertical bars (n= 3-4 mice/ group, ~p<0.05 using the Student's t-test). 
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The mycobacterial load in the LBP+/+ mice was stable between days 31 and 55 , but in the 
LBP-/- mice, there was significant growth in the liver and lungs (Fig. 3.14A and Fig. 3.14C). 
There was no significant difference in the spleen CFU between the two groups (Fig. 3.14B). 
3. 2.5 Analysis of Organ weights of LBP+I+ vs .. LBP-1- mice 
During necropsy, the masses of the liver, spleen and lungs were recorded and later expressed 
as a ratio of the respective mouse body weight (BW). These calculations give an indication of 
the developing inflammatory response with respect to the cellular recruitment within the 
organs. 
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Fig. 3.15: Analysis of organ weights: BW ratio. (A) liver expressed as a ratio of BW, (B) Spleen expressed 
as a ratio of BW, and (C) Lungs expressed as a ratio of BW (n=3-4 mice/ grouptf p< 0.05, trk P < 0.01 
using the student t-test) 
The most significant difference was observed when comparing the lung: BW ratio of the 
LBP-/- to those of the LBP +/+ (Fig 3. l 5C), indicating enhanced inflammation in the 
C3H/HeJ lungs. This ratio is skewed by the increased LBP-/- weight loss (Fig. 3.13B), but the 
relevance of the observation is supported by macroscopic evidence (Fig. 3 .16). There is no 
significant difference in the lung: BW ratio of the two groups up to two months, but 
thereafter, the LBP-/- lungs become massively congested and the ratio is about two-fold 
greater than the LBP+/+ lungs. The LBP+/+ spleen: BW ratio is initially much larger than the 
LBP-/- spleen: BW ratio, but as the infection progresses, the spleen: BW ratios become 
comparable in the two groups (Fig. 3.l5B). There is no significant trend in the liver: BW ratio 
between the two groups (Fig. 3.15A). 
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3.2.6 Macroscopic Inspection of the Organs of the LBP+/+ vs. LBP-1- mice 
The organs were inspected during necropsy and any macroscopic differences noted. 
LBP+/+ LBP-/-
Uninfected 
Infected 
Fig. 3.16: Macroscopic inspection of the lungs of the LBP+/+ vs. LBP-/- mice. Uninfected lungs were taken 
from naive mice. Infected lungs were taken from mice 14 weeks post-infection (n=3 mice/ group). 
The macroscopic analysis indicates that the LBP+/+ lungs are covered with necrotic lesions, 
whereas these lesions are absent in the LBP-/- lungs. The LBP-/- lungs are significantly larger 
than the LBP+/+ lungs, indicating a greatly enhanced inflammatory process. 
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3.2 .7 Histological analysis of LBP+/+ vs. LBP-/- mice infected with M.tuberculosis 
Fig. 3.17: Microscopic alterations in lungs of LBP+/+ (left panels) and LBP-/- mice (right panels) 32 clays 
(A, B) and 55 days (C, D) post aerosol Mtb infection using HE stains (histolog.v performed on 2 sections 
per mouse, 3-_. mice per group) 
HE stains of lung sections at 32 days post-infection revealed that there was a comparable level of 
inflammation in the two groups of mice . Lymphocytic infiltration appeared normal in the two 
groups of mice. At 55 days however the LBP-/- lungs appeared significantly more congested than 
the LBP+/+ 1 ungs with increased obstruction of airspace. Large areas of foamy macrophages were 
seen in lungs from both groups, but appeared to be more prominent in the LBP-/- lungs. 
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Fig. 3.18: Z tain for acid-fast bacilli (A-D) and iNOS2 (E,F) in lungs of LBP+/+ (left panels) and LBP-/-
mi (right pan I ) 32 da~· · ( ,B), 56 da~· · (C,D) and 56 da~·s (E,F) post aerosol M.tb infection 
(hi ·tolog_v perform cl on 2 ectioo per mouse, 3-t mice per group) 
Th Z tain re ealed that at 32 da s post-infection there was a comparable le el of AFBs 
in th lun0 of both groups of mice (Fig. 3.18A and Fig. 3. l 8B), and no noticeable 
diffi r n e in FBs after 55 da s (Fig. 3. l 8C and Fig. 3 l 8D). The i OS2 stain indicated there 
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was no difference in the expression of iNOS2 between the two groups at 55 days post-infection 
(Fig. 3.I8E and Fig. 3.18F). 
Fig. 3.19: Microscopic alterations in livers of LBP+/+ (left panels) and LBP-/- mice (right panels) 32 days 
(A,B) and 55 days (C,D) post aerosol Mtb infection using HE stains (histolo~· performed on 2 sections 
per mouse, 3--t mice per group). 
The HE stain in the li ver revealed that 32 days post-infection there is a similar inflammatory 
response in the LBP+/+ and LBP-/- with respect to granulomata development. At 55 days post-
infection however, there appears to be an increased granulomatous response in the liver of the 
LBP-/- when compared to the LBP+/+ Ii ver. 
In conclusion, these preliminary data demonstrate that LBP is required for host resistance to M tb 
infection . Therefore, the two components of the endotoxin response system investigated, TLR4 
and LBP. are both reauired to control infection. 
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3 Discussion 
In this thesis I investigated the in vivo role of pattern recognition receptors (PRR) in M tb 
infection. Recognition of pathogens by PRR leads to activation of antigen presenting cells and 
induction of a strong innate immune response. Among the PRR, I have focused on the 
endotoxin receptors, which comprise primarily CD14, LBP and TLR4. As the CD14 KO 
mouse was unavailable during this study, I investigated the TLR4 mutant and the LBP KO in 
aerosol Mtb infection. In view of the recently published in vitro data demonstrating TLR-
dependent cellular activation in a CD14 and LBP independent manner, our in vivo data is 
surprising (29) 
4.1 The Role of TLR4 in the Induction of Protective Immunity to 
Mycobacterium tuberculosis 
Chinese Hamster Ovary (CHO) fibroblast cells transfected with CD14 and TLR2, but not 
TLR4, acquire the ability to be activated by the mycobacterial cell wall glycolipid 
lipoarabinomannan (LAM). Subsequently, it was discovered that arabinosylated LAM 
(AraLAM) derived from rapidly growing mycobacteria could activate the CHO cells in a 
TLR2 dependent manner, whereas Mtb derived mannosylated LAM (ManLAM) could not. In 
contrast to this, live Mtb bacilli mediated cellular activation of the TLR-expressing CHO 
cells suggesting Mtb derived TLR ligands distinct from LAM. Cellular activation mediated 
by live Mtb was demonstrated to occur in a TLR2- and TLR4-dependent manner using TLR-
transfected CHO cells and RA W264.7 macrophages. This activation was shown to be 
independent of LBP or membrane-bound CD14 (29). A heat-labile cell-associated 
mycobacterial factor was found to activate CHO cells in a TLR4-dependent fashion while a 
soluble heat-stable mycobacterial factor mediated TLR2-dependent activation. Thus, TLR2 
and TLR4 are implicated in the recognition of M tb-derived PAMPs. 
Microbial lipoproteins, in particular the 19-kD antigen have been demonstrated in vitro to 
trigger host defence mechanisms in a TLR2-dependent manner ( 45) Strong induction of 
macrophage-derived IL-12 and NO were observed in response to this antigen, which was 
dramatically inhibited by TLR2 neutralising antibodies. The production of TNFa by 
macrophages has also been shown to be mediated primarily by TLR2 in response to Mtb . 
Induction of TNF a by M tb was demonstrated to be TLR2 specific, as the expression of an 
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inhibitory TLR2 in a macrophage cell line abrogated this response ( 46). Furthermore, the 
expression of TLR2 was sufficient to mediate Mtb-induced NF-KB expression in CHO cells. 
An investigation by Thoma-Uszynski et al. demonstrated the induction of direct anti-
mycobacterial activity through TLR2. Intracellular replication of Mtb within RA W264.7 was 
dramatically reduced when stimulated with the mycobacterial-derived 19kD lipoprotein 
(TLR2 ligand) (47). Importantly, TLR2-deficient macrophages did not respond to the 19kD 
lipoprotein, and displayed no reduction of intracellular growth. This inhibition was shown to 
be NO-dependent, as blocking the NO pathway with pharmacological inhibitors abrogated the 
anti-mycobacterial activity induced by the 19kD lipoprotein. In human monocytes and 
alveolar macrophages, similar anti-mycobacterial activity was induced by the 19kD 
lipoprotein, however, this was shown to be both NO and TNFa independent (47). In a study 
by Means et al, the LPS antagonist E5531, was demonstrated to dramatically reduce LPS and 
Mtb- induced TNFa production in RAW 264.7 macrophages and primary human alveolar 
macrophages (48), but did not effect the release of NO. Furthermore, Mtb infected peritoneal 
macrophages from TLR2- and TLR4-deficient mice generated comparable levels of NO to 
control mice. This investigation implicates TLR4 directly in Mtb-induced TNFa production, 
but suggests a TLR-2 and TLR-4 independent pathway for NO production ( 48). This is in 
contrast to the aforementioned study by Thoma-Uszynski et al, which demonstrates a role for 
TLR2 in M th-induced NO production. The cell wall skeleton of Mycobacterium bovis 
bacillus Calmette-Guerin (BCG-CWS), which consists of peptidoglycan, arabinogalactan and 
mycolic acids, was shown to induce the maturation of human dendritic cells ( 49). This BCG-
CWS induced maturation was demonstrated to be dependent on autocrine TNFa, as it was 
inhibited by anti-TNFa mAbs. Furthermore, this TNFa production was TLR-dependent, as 
TLR-2- and TLR4-deficient macrophages produced significantly less TNFa in response to 
BCG-CWS ( 49). This implies that APCs are activated by mycobacterial cell wall antigens in a 
TLR-dependent manner, and become further activated in an autocrine manner by soluble 
mediators (such as TNFa). In this study we demonstrate an important function of TLR4 in 
vivo in the induction of protective immunity to Mtb. 
In this investigation, we assessed the role of TLR4 in Mtb infection in vivo (approx. 100 
bacilli/lung at day 1 ). The natural mutant C3H/HeJ was used, which has a single-point 
mutation in the TLR4 gene rendering it dysfunctional (16,17). The C3H/HeJ mice were 
compared to C3H/HeN mouse, which express the wild-type allele of TLR4. In this study, the 
C3H/HeJ mice succumbed to the infection between 5 and 7 months, whereas no mortality was 
observed in the C3H/HeN mice during the duration of the experiment. The body weight 
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analysis of the mice revealed that the C3H/HeJ mice begin deteriorating from about 5 months 
post-infection before succumbing. These data demonstrate that TLR4 is an essential PRR in 
the induction of protective immunity to M tb in vivo, and that other PRRs cannot compensate 
for its function. 
The progression of the infection was monitored by determining the mycobacterial load (CFU 
analysis) in the liver, spleen and lungs. The pulmonary infection in the two groups progressed 
at a comparable rate up to 1 month, thereafter a significant difference was observed. Two 
months into the infection, the C3H/HeN mice effectively controlled the growth of the bacilli. 
In contrast, the C3H/HeJ mice were not able to suppress the infection, and at 5 months post-
infection the bacterial load was one log greater than that observed in C3H/HeN lungs. This 
trend was also observed systemically in the liver and spleen a month post-infection. 
Insignificant growth was observed in the liver and spleen of the C3H/HeN mice. Increased 
growth was observed in the liver of the mutants, Specifically, a one log higher CFU in the 
liver, and almost two logs greater in the spleen. Interestingly, there is no further bacterial 
growth in the C3H/HeJ lung between 13 and 20 weeks, which might indicate a delayed 
mycobacteriastatic mechanism in the mutant lung 
During necropsy, organs were removed, observed macroscopically, weighed and expressed as 
a ratio of the mouse's body weight. No significant difference was observed in the liver or lung 
ratio when comparing the two groups, thus indicating a normal level of inflammation in these 
organs. The increased splenomegaly observed in the C3H/HeJ mouse indicates that 
significantly increased cellular recruitment within this organ is associated with an increased 
bacterial burden. 
Development of the inflammatory response within the lung was found to be to be comparable 
in the two groups. Lung granulomata appear fully developed at 1 month, but there is a less 
pronounced lymphocytic presence in the C3H/HeJ lungs concomitant with an increased 
neutrophil component. This could indicate that macrophages present in the lung are unable to 
contain the infection, and as a compensatory mechanism, neutrophils are recruited to assist 
with the killing. Foamy macrophages appear at this stage of the infection, but become more 
prevalent as the infection develops. The number of hepatic granulomata and cellular 
composition is comparable at this stage, comprising a few diffuse structures. The quantity of 
acid-fast bacilli (AFBs) appears similar up to 2 months in the lungs. At 5 months post-
infection, AFBs were not readily detected in the C3H/HeN lungs, but were abundant in the 
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lungs of the mutants. This observation correlates with the CFU determination in the lungs. As 
the infection progresses, a greater inflammatory response is seen in the liver of the C3H/HeJ 
mice (approx. 5-fold more granulomata at 5 months) which corresponds with the greater CFU 
in the mutant liver. Surprisingly, immunohistochemistry (IHC) analysis revealed that the 
expression of the enzyme inducible nitric oxide synthase-2 (iNOS2) was comparable at 2 and 
5 months post-infection. This would indicate that the C3H/HeJ macrophages are in an 
activated state, and can generate RNI to mediate killing of bacilli. This finding might explain 
the apparent resistance observed in the lungs of the C3H/HeJ mice from 13 to 20 weeks, 
where no further increase in CFU is seen. To clarify this situation, IHC for iNOS2 should be 
performed at an earlier time point to determine whether this mechanism is delayed. Evidence 
from the literature however tends to support the above proposition. Specifically, in vitro RNI 
production is purportedly induced by the synergistic action of IFNy and TNFa ( 43). 
Greenberg et al. reported that in vivo intratracheal administration of heat-killed M tb resulted 
in rat alveolar macrophage-derived iNOS-2 mRNA expression and RNI independent ofTNFa 
production (50). This is further substantiated by the study of Means et al. ( 48), in which a 
TLR-2 and TLR-4 independent mechanism for M.tb-induced NO was indicated. These 
studies therefore support our finding of similar iNOS-2 expression in the lungs despite a 
significant difference in TNFa levels. 
Bronchoalveolar lavage (BAL) was performed at 4 weeks post-infection to investigate the 
nature of the cellular recruitment. No neutrophils were seen in the BALs taken from the 
C3H/HeN mice, but a significant level was observed in the BALs from the C3H/HeJ mice. 
The continuing neutrophil recruitment might be a compensatory mechanism deployed by the 
mutant to control the infection, albeit unsuccessfully. A neutrophil response has been shown 
to be effective against fast growing bacilli, but has been proposed to be relatively ineffective 
in retarding the replication of slow replicating bacilli such as Mtb (51). A significant decrease 
in the proportion of macrophages was also observed in the BAL samples taken from the 
C3H/HeJ mice, which would also effect their ability to contain the infection. The lymphocyte 
composition in the BAL fluid was comparable in the two groups. 
To assess the level of pro-inflammatory cytokines, BAL fluid and lung homogenates were 
analysed for the presence of IL-12p40, IFNy, TNFa and the chemokine MCP-1. The 
production of IL-12p40, a component of the cytokine, IL-12 which promotes the emergence 
of TH 1, IFNy-producing T cells ( 4 ), was shown to be significantly lower in both the BAL fluid 
and the lung homogenate of the C3H/HeJ mouse. This reduced level of IL-12p40 might be a 
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consequence of reduced macrophage induction due to defective TLR4 expression. A similar 
decrease in IL-12 production by C3H/HeJ peritoneal macrophages was recently noted in 
response to an array of Gram-negative and -positive microorganisms tested (52). The 
significance ofIL-12 in the protective immune response to Mtb has been demonstrated with 
anti-IL-12 neutralising antibodies, which resulted in impaired resistance, diffuse hepatic 
granulomata and a reduction in total mononuclear cell accumulation (53). In humans deficient 
in the IL-12 receptor (IL-12R), an impairment of mycobacterial immunity is seen concomitant 
with a decrease in IFNy production by activated NK cells and T cells (54). Furthermore, mice 
deficient for IL-12p40, display dramatically reduced protective immunity to M. tb, and 
succumb to the infection (38). IFNy is absolutely required for the activation of macrophages 
and the subsequent development of granuloma during a Mtb infection (55). IFNy-deficient 
mice are highly susceptible to Mtb, and succumb rapidly to infection. (35). A decrease in 
IFNy production was observed in the BAL fluid (data not shown) and lung homogenates of 
the C3H/HeJ mice as a consequence of reduced APC-derived IL-12, but not at a significantly 
lower level. TNFa secretion during mycobacterial infection has been shown to mediate 
essential functions including the upregulation of vascular adhesion molecules (5) and the 
recruitment of mononuclear cells for the formation of granuloma (39,40). TNFa was 
produced comparably in the BAL fluid, but was significantly lower in the lung homogenates 
of the C3H/HeJ mice. This finding of decreased TNFa is supported by the studies of Tsuji et 
al ( 49) and Means et al ( 48), which demonstrate a role for TLR2 and TLR4 in mycobacteria-
induced TNFa production. This difference in TNFa secretion can be a result of (i) a lower 
proportion of TNFa-secreting macrophages observed in the BAL fluid and/or (ii) impaired 
macrophage function/activation. Taken together the cytokine analysis corroborates our 
findings of increased susceptibility of C3H/HeJ mice at the systemic level. 
The chemokine MCP-1, released predominantly by macrophages, attracts T lymphocytes and 
monocytes, which are primary components of the granulomatous response ( 41 ). Studies 
addressing the role of MCP-1 in M tb infection have been controversial. Mice treated with 
anti-MCP-1 antibodies had normal granuloma formation when exposed to beads coupled to 
purified protein derivative (PPD) of Mtb (56). Surprisingly, MCP-1-deficient mice were 
indistinguishable from wild-type mice in their ability to clear an intravenous infection with 
M.tb (57), but aerosol challenge might yield different results. However, MCP-1 levels in 
patient's BAL fluid increase with a pulmonary tuberculosis infection, and decline during 
recovery, confirming an association between active tuberculosis with enhanced MCP-1 
production (42). No MCP-1 was detected in the BAL fluid of C3H/HeN or C3H/HeH mice, 
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but was measurable in the lung homogenates at 4 weeks post-infection. This might indicate 
that MCP-1 is present in the interstitium at this time point, but not in the alveolar spaces. The 
level of MCP-1 was significantly higher in the C3H/HeN lungs, which could account partly 
for the reduced macrophage population in the BAL fluid of the C3H/HeJ mice. 
In conclusion, we have shown TLR4 appears an essential component of protective immunity 
to Mtb. This PRR has systemic effects on mortality, control of bacterial burden, 
dissemination of infection, control of pro-inflammatory cytokines, and cellular recruitment. 
Further investigation is required to gain insight into the susceptibility of the C3H/HeJ mouse, 
namely: 
(i) IN0S2 IHC performed at earlier time points 
(ii) chemokine level analysis in the lungs to explain the differences observed in cellular 
recruitment. 
4.2 The Role of LBP in the Induction of Protective Immunity to 
M. tuberculosis 
It has been demonstrated that serum concentrations of LPS-activity modulating proteins, LBP 
and sCD14 are elevated in patients with active tuberculosis (58). During convalescence or 
treatment, the levels of these proteins declines suggesting they mediate a protective role. M tb 
uptake by human microglial cells has been shown to be inhibited significantly by the addition 
of anti-CD 14 antibodies or sCD 14. This activity was enhanced by the addition of LBP, which 
suggests that it facilitates Mtb-CD14 interactions, an analogous role mediated by LBP in the 
LPS response (33). Heat-killed Gram-positive bacteria activated CHO and HEK293 cells 
transfected with TLR2, but not TLR4 (59,60). Yoshimura et al. demonstrated that co-
expression of CD 14 with TLR2 in CHO cells significantly enhanced NF-KB translocation after 
exposure to heat-killed S.aureus. This data suggests that CD14 may act as a co-receptor for 
TLR proteins, enhancing the sensitivity of macrophages and neutrophils to pathogens (58). 
Furthermore, mycobacteria-induced NF-KB activation was enhanced by co-expressing CD14 
(34). In contrast to this, TLR-2 and TLR-4 expressing CHO cells mediate cellular activation 
by Mtb in a CD14 and LBP independent manner (29). These discrepancies reported for CD14 
and LBP might reflect species-specific differences in TLR recognition or subtle flaws in the 
experimental design of the in vitro studies ( 61 ). Given the above observations and our 
findings regarding TLR4, we investigated the role of LBP in in vivo Mtb infection. 
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LBP+/+ mice survived the duration of the experiment (approx. 100 bacilli/lungs at day 1), but 
LBP-/- mice succumbed to the infection between 9 and 19 weeks. Body weight analysis 
indicated that LBP-/- mice begin deteriorating at 11 weeks and succumb steadily thereafter. 
To investigate the development of the infection, the mycobacterial load in the liver, spleen 
and lungs were assessed. The CFU in these organs were comparable 31 days post-infection, 
but significantly increased growth in the LBP-/- liver was determined 55 days post-infection 
when compared to the LBP+/+ mice. The pulmonary infection appeared to be suppressed in 
the LBP+/+ mice at day 51, but increased significantly in the LBP-/- lungs. The spleen CFU 
was comparable in the two groups. This demonstrates that the liver and lungs of LBP-/- mice 
have difficulty in controlling the Mtb infection. LBP+/+ spleen ratio to body weight (BW) 
was initially larger than the LBP-/- spleen to BW ratio, but as the infection progressed, the 
LBP-/- spleen to BW ratio became comparable. A highly significant increase in the size of the 
LBP-/- lungs was observed 99 days post-infection (ratio to BW is about two-fold greater than 
the LBP+/+). Macroscopically, after 99 days, the LBP+/+ lungs appear severely necrotic with 
lesions covering the organ. In contrast, the LBP-/- lungs are massive compared to the LBP+/+ 
lungs, but have no necrotic lesions. This demonstrates that chronic pulmonary M. tb in 
LBP+/+ mice results in a hyperactive immune response leading to lung tissue necrosis. The 
LBP-/- mice, which have a more severe infection, appear to mount hyporesponsive immunity. 
This inability to control the infection in the LBP-/- mice leads to exacerbated cellular 
recruitment into the lungs, congestion and death. This data is supported by the histological 
analysis, which reveals a dramatic increase in cellular infiltration in the mutant lungs at day 
99 and obstruction of air spaces. There were no difference in the ability to generate NO in the 
lungs at the time point analysed (as assessed by iNOS2 reactivity at day 32) between the two 
groups of mice. In conclusion, preliminary data from this study reveals a role for LBP in M tb 
infection. LBP has systemic effects on mortality, control of bacterial burden and 
dissemination of infection. Further investigation is required to gain insight into the 
susceptibility of the LBP-/- mice, namely: 
(i) The levels of pro-inflammatory cytokines produced, such as IL-12, IFNy and 
TNFa. 
(ii) The nature of cellular recruitment into the lungs. 
(iii) An extended CFU study performed to observe the progression of pulmonary infection. 
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However, it should be noted that the results with the LBP-/- mice and Mtb are 
preliminary and should be subjected to careful analysis. The LBP-/- mice are on a mixed 
genetic background (BALB/c x 129sv), whereas the control mice used are on a pure 
BALB/c background. This obscures the analysis as the LBP-/- mice have a mixed 
MHC haplotype (H-2dxb) and the wild-type mice have an H-2d haplotype. The difference 
in MHC molecules would result in different peptide affinities, peptide presentation and 
an altered response. Furthermore, the difference in genetic backgrounds might lead to a 
variation in host resistance or susceptibility genes, which may further confuse the 
analysis. I would speculate that the significant differences observed cannot be merely 
attributed to the genetic backgrounds, but these results must be confirmed with 
appropriate controls. 
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4.3 Summary 
In this investigation we demonstrate a role for the endotoxin receptors TLR4 and LBP in the 
induction of protective immunity to pulmonary Mtb infection. TLR4 is an essential pattern 
recognition receptor for the early detection of a M tb infection in the host and the subsequent 
triggering of the innate immune response. In the absence of TLR4, C3H/HeJ mice display 
increased susceptibility to M tb infection and succumb to the infection. 
Preliminary studies with LBP indicate that it is an essential component of this mycobacterial 
recognition system. We propose the following mechanism: After infection with Mtb, LBP 
facilitates the transfer of M th-derived P AMPs (yet to be identified) to the surface of APCs, 
where they engage the 'LPS' receptor complex CD14/TLR4 (refer to the figure below). 
Signalling events take place leading to NFKB activation and subsequent transcription of pro-
inflammatory genes . 
• 
••• 
• • • + 
•• 
APC 
I M.tb PAMP 1, LBP 11, M.tb PAMP-LBP C., CD14?/TLR4 
Fig. 1.4: Hypothetical mechanism of macrophage activation by M.tb 
Activated APC 
M.tuberculosis-derived PAMPs (M.tb-PAMPs) are transferred to the surface of antigen-presenting cells by 
LBP, where interaction with TLR-2 or -4 occurs. The role of CD14 in mycobacterial recognition and APC 
activation has yet to be defined. 
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6. Appendices 
ABBREVIATIONS: 
AFB 
•
1
• mice 
BW 
dd 
DNA 
DNTP 
EDTA 
ELISA 
ES cells 
EtBr 
H20 
IFNy 
IL 
INOS 
1.p 
l.V 
Kb 
KD 
KO 
LCs 
LPS 
M 
MCs 
MCP-1 
MHC 
Mins 
NK cells 
NO 
NTs 
o/n 
PBS 
acid-fast bacilli 
mice homozygous deficient for specified gene 
body weight 
double-distilled 
deoxyribonucleic acid 
deoxyribonucleoside triphosphate 
ethylenediaminetetraacetic acid 
enzyme-linked immunosorbent assay 
embryonic stem cells 
ethidium bromide 
water 
interferon gamma 
interleukin 
inducible nitric oxide synthase 
intraperitoneal 
intravenous 
kilo-bases, length measurement of DNA 
kilo Dalton 
'knockout', genetically deficient 
lymphocytes 
lipopolysaccharide 
molar 
macrophages 
macrophage chemotactic protein 1 
major histocompatibility complex 
minutes 
natural killer cells 
nitric oxide 
neutrophils 
over night 
phosphate buffered saline 
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PCR polymerase chain reaction 
RNI reactive nitrogen intermediate 
RO retro-orbital 
Secs seconds 
SPF specific pathogen free 
TH T-helper 
TNFa tumour necrosis factor alpha 
WT wild-type 
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Antibodies and Recombinant Cytokines/ Chemokines Used in ELISA 
detection 
COATING STANDARD CAPTURE 
CYTOKINE/ ANTIBODY (PURIFIED ANTIBODY 
CHEMOKINE (WORKING CYTOKINE/ (WORKING 
CONC.) CHEMOKINE CONC.) 
a-IL-12p40 r-IL-12p40 Biotinylated-
mAb (#19401W) a-IL-12p40/p70 
Il-12p40 (#184910) mAb (IOOng/ml) (#18482D) 
1:1000 1:1000 
a-IFNy mAb r-IFNy Biotinylated-
IFNy (#1811 IA) (#19301T) 
a-IFNy mAb 
(#18112D) 
1:500 (IOOng/ml) 1:1000 
a-TNFamAb r-TNFa Biotinylated-
TNFa (#181310) (#19321T) 
a-TNFamAb 
(#18122D) 
1:1000 (IOOng/ml) 1:1000 
a-MCP-1 mAb r-MCP-1 Biotinylated-
MCP-1 (#182410) (#19341
V) a-MCP-1 mAb 
(#18272D) 
1:500 (IOOng/ml) 1:1000 
All antibodies utilised were purchased from Pharmingen. 
Sensitivities: 
IL-12p 
IFNy 
TNFa 
MCP-1 
100 pg/ml 
15 pg/ml 
45 pg/ml 
45 pg/ml 
ENZYME 
LABEL 
(WORKING 
CONC.) 
Streptavidin-
alkaline 
Phosphatase 
(#13043E) 
(I :1000) 
Streptavidin-
alkaline 
Phosphatase 
(#13043E) 
(1:1000) 
Streptavidin-
alkaline 
Phosphatase 
(#13043E) 
(I :1000) 
Streptavidin-
alkaline 
Phosphatase 
(#13043E) 
(I :1000) 
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Reagents and Chemicals 
Agarose agarose gel (PCR) Whitehead Scientific 
Boric Acid TBE buffer Merck 
Bromophenol blue loading buffer Merck 
BSA fraction V buffers Sigma 
Chloroform DNA extraction Sigma 
Diethyl-ether anaesthetic AnalaR 
DNTPs PCR reaction Promega 
EDTA TBE buffer Roth 
Ethanol DNA extraction Anala R 
Ethidium bromide DNA staining Fluka 
Formaldehyde tissue fixation Merck 
Gelatine PCR buffer Sigma 
Glucose PCR buffer Anala R 
Glycerol M tb culturing Sigma 
Heparin anti-coagulant Pharmacare-limited 
Isopropanol DNA extraction Gibco 
KCl buffers Merck 
K2HP04 buffers Merck 
LPS endotoxin challenge Sigma 
Middlebrook 7H9 Mtb culturing Difeo 
Middlebrook 7H 10 Agar plates Difeo 
MgCli.6H20 buffers AnalaR 
NaCl buffers Merck 
NaH2P04 buffers MERCK 
OADC enrichment Mtb culturing State Vaccine Institute 
p-Nitrophenylphosphate ELISA Boehringer Mannheim 
Proteinase K tail digestion Sigma 
Rapidiff Kit differential counts Clin. Sciences Diagnostics 
SDS lysis buffer Pharmingen 
Sodium azide preservative Merck 
Taq enzyme Super-Therm DNA polymerase Biorad 
Tris-base TBE buffer Sigma 
Tris-HCl lysis buffer Sigma 
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Tris pH 9 PCR buffer Sigma 
Trypan blue cell counting Sigma 
Tween20 washing buffer (ELISA) Sigma 
Tween80 
Xylene-cyanol loading buffer BHD chemicals 
